1,25-Dihydroxyvitamin D 3 and retonic acid analogues induce differentiation in breast cancer cells with function- and cell-specific additive effects

Breast Cancer Research and Treatment

Volumn 67, Issue 2, 2001, Pages 157-168

  Wang, Q ^a   Lee, D ^a   Sysounthone, V ^a   Chandraratna, R A S ^b   Christakos, S ^a   Korah, R ^a   Wieder, R ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b ALLERGAN INC   (United States)

Author keywords

1,25(OH) 2 vitamin D 3; All trans retinoic acid; Cell cycle; Differentiation; Proliferation

Indexed keywords

AGN 195183; CALCITRIOL DERIVATIVE; PROTEIN P21; PROTEIN P27; RECEPTOR SUBTYPE; RETINOBLASTOMA PROTEIN; RETINOIC ACID DERIVATIVE; RETINOIC ACID RECEPTOR; TAZAROTENE; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; BREAST CANCER; CELL CYCLE G1 PHASE; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG POTENTIATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR DIFFERENTIATION;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CALCITRIOL; CALCIUM CHANNEL AGONISTS; CELL CYCLE; CELL DIFFERENTIATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PHENOTYPE; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0034889853     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010643323268     Document Type: Article

References (61)

1. Growth-inhibitory effects of vitamin D analogues and retinoids on human pancreatic cancer cells
2. Effects of retinoic acid on cell differentiation and reversion toward normal in human endometrial adenocarcinoma (REL95- 2) cells
3. Effects of vitamin D and retinoids on the differentiation and growth in vitro of canine osteosarcoma and its clonal cell lines
4. 3 and 9-cis retinoic acid in LNCaP human prostate cancer cells
5. EB 1089, a novel vitamin D analogue, has strong antiproliferative and differentiation inducing effects on cancer cells
6. A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents
7. Nuclear receptors enhance our understanding of transcription regulation
8. Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors
9. 3 signalling
10. RXR beta: A coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements
11. Interaction between retinoic acid and vitamin D signalling pathways
12. 3 and 9-cis-retinoic acid act synergisticafly to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G1
13. 3 analogue and anti-activator protein 1 retinoid
14. Potentiation of VD-induced monocytic leukemia cell differentiation by retinoids involves both RAR and RXR signaling pathways
15. Leukemia cell differentiation: Cellular and molecular interactions of retinoids and vitamin D
16. The role of vitamin D derivatives and retinoids in the differentiation of human leukemia cells
17. 3 analog and all-trans-retinoic acid: Effect on human breast cancer in nude mice
18. 3 in human skin in vivo
19. 3 in normal human keratinocytes
20. Effects of vitamin D3 on keratinocyte proliferation and differentiation in vitro: Modulation by ligands for retinoic acid and retinoid X receptors
21. 9-cis retinoic acid antagonizes the stimulatory effect of 1,25 dihydroxyvitamin D3 on chondrogenesis of chick limb bud mesenchymal cells: Interactions of their receptors
22. All-trans retinoic acid inhibits binding of 1,25 dihydroxy-vitamin D3 to the vitamin D receptor in cultured human keratinocytes
23. Vitamin D-retinoid association: Molecular basis and clinical applications
24. 3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death
25. Low level expression of basic FGF upregulates Bcl-2 and delays apoptosis, but high intracellular levels are required to induce transformation in NIH 3T3 cells
26. Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O
27. Androgens markedly stimulate the accumulation of neutral lipids in the prostatic adenocarcinoma cell line LNCaP
28. Misregulation of stromelysin-1 expression in mouse mammary tumor cells accompanies acquisition of stromelysin-1-dependent invasive properties
29. Selection of Methods for Measuring Proliferation
30. 1 events
31. Basic fibroblast growth factor confers growth inhibition and Mitogen-activated Protein Kinase activation in human breast cancer cells
32. The search for synergy: A critical review from a response, surface perspective
33. In vitro modulation of human melanoma cell invasion and proliferation by all-trans-retinoic acid
34. 1 alpha,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells
35. Basic fibroblast growth factor confers a more differentiated phenotype in MDA-MB-231 human breast cancer cells
36. Dysregulated expression of cyclin D1 in normal human mammary epithelial cells inhibits all-trans-retinoic acid-mediated GO/G1-phase arrest and differentiation in vitro
37. Milk protein synthesis by mammary glands of vitamin D-deficient mice
38. Differentiation induction in human breast tumor cells by okadaic acid and related inhibitors of protein phosphatases I and 2A
39. Differentiation of cultured human breast cancer cells (AU-565 and MCF-7) associated with loss of cell surface HER-2 /neu antigen
40. 3 and the retinoid CD437 in the induction of human melanoma cell apoptosis
41. 3 analogues: A novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines
42. 1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells
43. Upregulation of cytokeratins 8 and 18 in human breast cancer T47D cells is retinoid-specific and retinoic acid receptor-dependent
44. WAF1/Cip1 gene by retinoic acid receptor; correlation with retinoid induction of U937 cell differentiation
45. Transcriptional activation of the cdk inhibitor p21 by vitamin D3 leads to induced differentiation of the myelomonocytic cell line U937
46. Selective effects of ligands on vitamin D3 receptor- and retinoid X receptor-mediated gene activation in vivo
47. Induction of apoptosis in MCF-7 breast carcinoma cell line by RAR and RXR selective retinoids
48. Progressive decrease in nuclear retinoic acid receptor beta messenger RNA level during breast carcinogenesis
49. Identification of novel, stage-specific polypeptides associated with the differentiation of mammary epithelial stem cells to alveolar-like cells in culture
50. Modulation of normal mammary epithelial cell proliferation, morphogenesis, and functional differentiation by retinoids: A comparison of the retinobenzoic acid derivative RE80 with retinoic aci
51. Effect of retinoic acid on morphological changes of human pancreatic cancer cells on collagen gels: A possible association with the metastatic potentials
52. Kip1 and E-cadherin
53. Human breast cancer cells activate procollagenase-1 and invade type I collagen: Invasion is inhibited by all-trans retinoic acid
54. A novel host/tumor cell interaction activates matrix metalloproteinase I and mediates invasion through type I collagen
55. Retinoid-mediated suppression of tumor invasion and matrix metalloproteinase synthesis
56. Urokinase-mediated extracellular matrix degradation by human prostatic carcinoma cells and its inhibition by retinoic acid
57. Regulation of the invasion suppressor function of the cadherin/catenin complex
58. Transcriptional repression of the human collagenase-1 (MMP-1 gene in MDA231 breast cancer cells by all-trans-retinoic acid requires distal regions of the promoter
59. Retinoic acid modulates extracellular urokinase-type plasminogen activator activity in DU-145 human prostatic carcinoma cells
60. Alpha2betal integrin signaling via the mitogen activated protein kinase pathway modulates retinoic acid-dependent tumor cell invasion and transcriptional downregulation of matrix metalloproteinase 9 activity
61. Retinoic acid stimulates meningioma cell adhesion to the extracellular matrix and inhibits invasion